World News

How It Compares to Wegovy

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

  • Lindsey Buckingham Attacked by Alleged Stalker in California

    00:26

  • Judges Postpone Luigi Mangione’s State and Federal Trials

    00:33

  • Hear What the Artemis II Astronauts Said Upon Liftoff

    03:42

  • Top Travel Tips and Deals to Set out on Vacation With Ease

    05:09

  • Meet the Viral Catholic Nuns Inspiring a New Generation

    04:29

  • Gmail Users Can Now Change Their Account Address

    00:57

  • Supreme Court Casts Doubt on Trump Birthright Citizenship Order

    01:55

  • Young Boy’s Birthday Surprise of WWE Tickets Brings Him to Tears

    01:03

  • Now Playing

    FDA Approves Eli Lilly’s New Weight Loss Pill Foundayo

    03:11

  • UP NEXT

    Hawaii Doctor Takes the Stand in Attempted Murder Trial

    02:19

  • Tiger Woods Granted Permission to Leave US for Treatment

    00:27

  • Trump Vows to Hit Iran ‘Extremely Hard’ in Coming Weeks

    05:50

  • Artemis II Roars Into Space in Groundbreaking Moon Mission

    05:37

  • Hershey’s to Return to Pure Chocolate Ingredients in All Recipes

    00:32

  • Influencer Shines Light on Struggling Family-Owned Restaurant

    04:56

  • Get an Inside Look at How Fiesta Tableware Products Are Made

    05:00

  • More Americans Are Taking on Side Hustles to Make Extra Cash

    04:06

  • Why Las Vegas Hotels Are Rolling the Dice on All-Inclusive Options

    03:10

  • A Look Back at Apple’s History and Impact as It Marks 50 Years

    05:40

  • Trump to Attend Supreme Court Birthright Citizenship Hearing

    01:50

The Food and Drug Administration on Wednesday approved Eli Lilly’s new GLP-1 daily pill called Foundayo. It’s a new option for the millions looking to try weight loss drugs without having to use a needle and it’s set to hit the market next week. It follows the approval of Novo Nordisk’s Wegovy pill in December. NBC’s Anne Thompson reports for TODAY.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button